换一批
换一批High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.
第一作者：
Lesley A,Mathews Griner
第一单位：
Division of Preclinical Innovation, National Institutes of Health Chemical Genomics Center, National Center for Advancing Translational Sciences, Metabolism Branch, Center for Cancer Research, and Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
作者：
主题词
腺嘌呤(Adenine);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);B-淋巴细胞(B-Lymphocytes);细胞系, 肿瘤(Cell Line, Tumor);高通量筛选分析(High-Throughput Screening Assays);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);哌啶类(Piperidines);吡唑类(Pyrazoles);嘧啶类(Pyrimidines)
DOI
10.1073/pnas.1311846111
PMID
24469833
发布时间
2024-06-15
- 浏览106
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
